ArticleGlobalization and health2016
Addressing antimicrobial resistance in China: policy implementation in a complex context.
Article in Globalization and health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic synthesis of expert opinion on effective policies to tackle bacterial resistance worldwide.Veterinary medicine and science · 2023Pooled it
- Use of multiple metrics and clustering analysis to assess antimicrobial use in Shanxi hospitals, China: a cross-sectional study based on 25 general hospitals.Frontiers in public health · 2025Article
- Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.Health policy and planning · 2022Article
- Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.BMC infectious diseases · 2020Article
- Article
- Survey of Parental Use of Antimicrobial Drugs for Common Childhood Infections, China.Emerging infectious diseases · 2020Article
- Patients without records and records without patients: review of patient records in primary care and implications for surveillance of antibiotic prescribing in rural China.BMC health services research · 2020Article
- Label-Free Electrochemical Microfluidic Chip for the Antimicrobial Susceptibility Testing.Antibiotics (Basel, Switzerland) · 2020Article
- Antibiotic Consumption Trends in China: Evidence From Six-Year Surveillance Sales Records in Shandong Province.Frontiers in pharmacology · 2020Article
- Crisis of Antimicrobial Resistance in China: Now and the Future.Frontiers in microbiology · 2019Article
- Enlisting the support of trusted sources to tackle policy problems: The case of antimicrobial resistance.PloS one · 2019Article
- Probing popular and political discourse on antimicrobial resistance in China.Global health research and policy · 2019Article
- The impact of the national action plan on the epidemiology of antibiotic resistance among 352,238 isolates in a teaching hospital in China from 2015 to 2018.Antimicrobial resistance and infection control · 2019Article
- The impact of prescriptions audit and feedback for antibiotic use in rural clinics: interrupted time series with segmented regression analysis.BMC health services research · 2018Article
- Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China.Cost effectiveness and resource allocation : C/E · 2018Article
- ICTs and the challenge of health system transition in low and middle-income countries.Globalization and health · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The effectiveness of antibiotics in treating bacterial infections is decreasing in China because of the widespread development of resistant organisms. Although China has enacted a number of regulations to address this problem, but the impact is very limited. This paper investigates the implementation of these regulations through the lens of complex adaptive systems (CAS). It presents the findings from reviews of relevant policy documents and published papers. The paper identifies different types of agent and explores their interaction with regard to the use of antibiotics and their responses to changes of the regulations. It focuses particularly on the impact of perverse financial incentives on overall patterns of use of antibiotics. Implications for the possibilities of nonlinear results, interactive relationships, and new pathways of policy implementation are discussed. The paper concludes that policy-makers need to better understand the objectives, incentives and potential adaptive behaviors of the agents when they implement interventions to improve antibiotic use and reduce the risk of emergence of resistant organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.